GenMont Biotech Incorporation (TPE:3164)
17.95
-0.05 (-0.28%)
Mar 4, 2026, 1:35 PM CST
-11.58% (1Y)
| Market Cap | 1.54B -11.0% |
| Revenue (ttm) | 391.48M +6.2% |
| Net Income | 34.49M -35.1% |
| EPS | 0.39 -36.5% |
| Shares Out | 86.01M |
| PE Ratio | 46.03 |
| Forward PE | n/a |
| Dividend | 0.80 (4.46%) |
| Ex-Dividend Date | Mar 27, 2025 |
| Volume | 120,234 |
| Average Volume | 95,045 |
| Open | 17.95 |
| Previous Close | 17.95 |
| Day's Range | 17.50 - 18.00 |
| 52-Week Range | 17.20 - 23.35 |
| Beta | 0.21 |
| RSI | 47.70 |
| Earnings Date | Mar 13, 2026 |